These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25844674)

  • 21. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
    Oien KA; Dennis JL
    Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
    Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
    J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic management of inaugurable metastases].
    Penel N
    Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
    Magnusson K; de Wit M; Brennan DJ; Johnson LB; McGee SF; Lundberg E; Naicker K; Klinger R; Kampf C; Asplund A; Wester K; Gry M; Bjartell A; Gallagher WM; Rexhepaj E; Kilpinen S; Kallioniemi OP; Belt E; Goos J; Meijer G; Birgisson H; Glimelius B; Borrebaeck CA; Navani S; Uhlén M; O'Connor DP; Jirström K; Pontén F
    Am J Surg Pathol; 2011 Jul; 35(7):937-48. PubMed ID: 21677534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
    Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic challenges of patients with carcinoma of unknown primary.
    Rassy E; Pavlidis N
    Expert Rev Anticancer Ther; 2020 Sep; 20(9):775-783. PubMed ID: 32779501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The CUP syndrome--malignant disease with unknown primary tumor. Part 3: Metastatic site--tumor markers].
    Jaspersen D
    Fortschr Med; 1992 Nov; 110(30):562-4. PubMed ID: 1468742
    [No Abstract]   [Full Text] [Related]  

  • 30. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.
    Bellizzi AM
    Adv Anat Pathol; 2013 Sep; 20(5):285-314. PubMed ID: 23939147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carcinoma unknown primary-clinical practice].
    Onozawa Y
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):799-803. PubMed ID: 25131862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous Metastases: A Review and Diagnostic Approach to Tumors of Unknown Origin.
    Habermehl G; Ko J
    Arch Pathol Lab Med; 2019 Aug; 143(8):943-957. PubMed ID: 30605024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the diagnosis of cancer of unknown primary (CUP) origin.
    Ariza A; Balañá C; Concha Á; Hitt R; Homet B; Matilla A; Alba E
    Clin Transl Oncol; 2011 Jul; 13(7):434-41. PubMed ID: 21775269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
    Chen ZE; Lin F
    Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
    Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
    Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic strategies for unknown primary cancer.
    Varadhachary GR; Abbruzzese JL; Lenzi R
    Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor markers in metastatic disease from cancer of unknown primary origin.
    Milović M; Popov I; Jelić S
    Med Sci Monit; 2002 Feb; 8(2):MT25-30. PubMed ID: 11859288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry of colorectal carcinoma: current practice and evolving applications.
    Taliano RJ; LeGolvan M; Resnick MB
    Hum Pathol; 2013 Feb; 44(2):151-63. PubMed ID: 22939578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.